Patents Assigned to Novogen, Inc.
-
Publication number: 20110312906Abstract: There is described a method for the treatment or prevention of menopausal symptoms or osteoporosis wherein there is administered to a subject in need of such treatment a therapeutically effective amount of the isotlavone formononetin, or a method for the treatment or prevention of menopausal symptoms wherein there is administered to a subject in need of such treatment a therapeutically effective amount of the isoflavone daidzein, the isotlavone being optionally administered with one or more pharmaceutically acceptable adjuvants, carriers and/or excipients. Therapeutic uses and compositions/foods are also described, comprising daidzein or formononetin optionally in association with one or more pharmaceutically acceptable adjuvants, carriers, food components and/or excipients.Type: ApplicationFiled: June 23, 2011Publication date: December 22, 2011Applicant: NOVOGEN, INC.Inventor: Graham E. Kelly
-
Patent number: 7033621Abstract: Processes for the production of isoflavones are described wherein plant material from plants of the genus leguminosae are contacted with water, an enzyme which cleaves isoflavone glycosides to the aglucone form and a C2-C10 organic solvent, so as to form a combination, incubating the combination for a time sufficient to allow isoflavones of the aglucone form to partition into the organic solvent component, and thereafter recovering isoflavones from the organic solvent component.Type: GrantFiled: April 11, 2000Date of Patent: April 25, 2006Assignee: Novogen, Inc.Inventors: Graham E. Kelly, Jiu Li Huang, Mark G. Deacon-Shaw, Mark A. Waring
-
Publication number: 20020035074Abstract: There is described a method for the treatment or prevention of menopausal symptoms or osteoporosis wherein there is administered to a subject in need of such treatment a therapeutically effective amount of the isoflavone formononetin, or a method for the treatment or prevention of menopausal symptoms wherein there is administered to a subject in need of such treatment a therapeutically effective amount of the isoflavone daidzein, the isoflavone being optionally administered with one or more pharmaceutically acceptable adjuvants, carriers and/or excipients. Therapeutic uses and compositions/foods are also described, comprising daidzein or formononetin optionally in association with one or more pharmaceutically acceptable adjuvants, carriers, food components and/or excipients.Type: ApplicationFiled: November 9, 2001Publication date: March 21, 2002Applicant: Novogen, Inc.Inventor: Graham E. Kelly
-
Patent number: 6340703Abstract: There is described a method for the treatment or prevention of menopausal symptoms or osteoporosis wherein there is administered to a subject in need of such treatment a therapeutically effective amount of the isoflavone formononetin, or a method for the treatment or prevention of menopausal symptoms wherein there is administered to a subject in need of such treatment a therapeutically effective amount of the isoflavone daidzein, the isoflavone being optionally administered with one or more pharmaceutically acceptable adjuvants, carriers and/or excipients. Therapeutic uses and compositions/foods are also described, comprising daidzeii or formononetin optionally in association with one or more pharmaceutically acceptable adjuvants, carriers, food components and/or excipients.Type: GrantFiled: June 2, 1998Date of Patent: January 22, 2002Assignee: Novogen, Inc.Inventor: Graham E. Kelly
-
Patent number: 6146668Abstract: Processes for the production of isoflavones are described wherein plant material from plants of the genus leguminosae are contacted with water, an enzyme which cleaves isoflavone glycosides to the aglucone form and a C.sub.2 -C.sub.10 organic solvent, so as to form a combination, incubating the combination for a time sufficient to allow isoflavones of the aglucone form to partition into the organic solvent component, and thereafter recovering isoflavones from the organic solvent component.Type: GrantFiled: April 28, 1997Date of Patent: November 14, 2000Assignee: Novogen, Inc.Inventors: Graham E. Kelly, Jiu Li Huang, Mark G. Deacon-Shaw, Mark A. Waring
-
Patent number: 6004558Abstract: The present invention relates to the preparation of therapeutic compositions comprising extracts of leguminous plants from which the isoflavones genistein, daidzein, formononetin and biochanin and/or their glycosides have been removed. The invention also relates to therapeutic uses of such extracts in the treatment, prophylaxis, amelioration of, or defense against a variety of cancers.Type: GrantFiled: February 25, 1998Date of Patent: December 21, 1999Assignee: Novogen, Inc.Inventors: Michael Joseph Thurn, Li Jiu Huang